Down-modulation of cancer targets using locked nucleic acid (LNA)-based antisense oligonucleotides without transfection

por Zhang, Y, Qu, Z, Kim, S, Shi, V, Liao, B, Kraft, P, Bandaru, R, Wu, Y, Greenberger, L M, Horak, I D
Publicado 2011